Gabapentin and Hair Loss: What the Evidence Shows
Gabapentin (Neurontin) and the closely related pregabalin (Lyrica) are among the most widely prescribed medications in the United States. They are used for nerve pain, fibromyalgia, restless legs syndrome, certain seizure disorders, and increasingly for anxiety and sleep. With that kind of prescribing volume, it is not surprising that some patients on these medications notice hair shedding and start searching for a connection. Search interest in "gabapentin hair loss" has roughly doubled over the past two years, so this is clearly on people's minds. What the evidence actually says is more measured than the search trend suggests.
This page summarizes what is known, what is uncertain, and how to think about the conversation with your prescriber if you suspect a link.
What gabapentin and pregabalin actually do
Gabapentin and pregabalin are gabapentinoids. Despite the name, they do not act directly on GABA receptors. They bind to a subunit of voltage-gated calcium channels in the nervous system, which dampens the release of certain excitatory neurotransmitters. The clinical effect is to reduce nerve hyperactivity, which is why they help with nerve pain and certain seizure types.
Neither drug has a known direct effect on hair follicle biology, and neither targets the DHT pathway that drives pattern hair loss. If gabapentinoids contribute to shedding, the mechanism is almost certainly indirect.
What the evidence actually shows
The honest summary: the published evidence linking gabapentin or pregabalin to hair loss is thin. Hair loss is not listed as a common side effect in the FDA label for either medication. It is mentioned in some post-marketing surveillance and case reports, but case reports are a low rung on the evidence ladder.
A few relevant data points:
- The FDA Adverse Event Reporting System (FAERS) has accumulated a modest number of alopecia reports for both gabapentin and pregabalin since they came to market. The reports describe diffuse shedding rather than patterned thinning.
- Case reports in the dermatology literature describe individual patients in whom hair loss began weeks to months after starting a gabapentinoid, improved after discontinuation, and recurred with rechallenge (Hilas and Avena-Woods, Journal of Pharmacy Practice, 2009). That pattern, called a positive dechallenge and rechallenge, is suggestive but is not the same as a controlled study.
- Larger pharmacoepidemiology studies have not consistently identified hair loss as an excess risk above baseline.
In plain terms: it is biologically plausible that gabapentinoids contribute to telogen effluvium in some patients, the case reports are real, and the absolute risk is probably low. That last point matters, because most patients on these medications are taking them for conditions where stopping carries its own cost.
The most likely mechanism: telogen effluvium
The pattern described in case reports is consistent with telogen effluvium: diffuse shedding, often noticed in the shower or on the pillow, beginning roughly two to four months after starting the medication. Telogen effluvium happens when a stressor (medication, illness, physical stress, hormonal shift) pushes a higher than usual proportion of follicles out of the active growth phase and into the resting phase. They shed in unison a few months later.
The two to four month delay is one of the most useful diagnostic clues. If shedding started within days or weeks of a new gabapentinoid prescription, the timing is wrong for telogen effluvium and the medication is unlikely to be the cause. If it started two to four months after starting or after a meaningful dose increase, telogen effluvium is plausible.
Telogen effluvium is also, importantly, reversible in most cases. When the trigger is removed or resolves, the resting follicles re-enter their growth cycle and density typically returns over six to twelve months.
What to actually do if you suspect a connection
The first instinct, especially after reading internet forums, is sometimes to stop the medication. Please do not do that on your own. Gabapentinoids should generally be tapered rather than stopped abruptly, particularly at higher doses or after long use, because abrupt discontinuation can produce withdrawal symptoms and, for patients with seizure disorders, can lower the seizure threshold. This is a conversation to have with the prescribing physician, not a decision to make unilaterally.
Some practical points to bring to that conversation:
- When did the shedding start? Be specific. Was it within four months of starting, or within four months of a dose increase?
- What else changed in that window? New medications, weight changes, illness, surgery, pregnancy, postpartum status, a major life stressor, a crash diet, or thyroid or iron issues are all common confounders. Sorting out which factor matters is the work of the visit.
- What is the medication treating? A patient managing seizures has a very different risk-benefit calculation than a patient using gabapentin off-label for mild sleep issues. The right next step depends on what is at stake.
- Are there alternatives? For many indications, alternatives exist. For nerve pain, options include duloxetine, certain tricyclics, or topical agents. For sleep, behavioral options often work better than any medication. For anxiety, several medication classes are available. None of these are automatically the right answer, but they are part of the conversation.
In some situations the prescriber may suggest staying on the medication, given that telogen effluvium tends to be self-limited and that the underlying condition the medication treats may be more disabling than the shedding.
What is probably not gabapentin
A few patterns of hair loss are unlikely to be caused by a gabapentinoid even if you happen to be taking one:
- Gradual receding hairline or crown thinning over years is much more consistent with pattern hair loss driven by DHT, and would not start or stop based on a gabapentin prescription.
- Patchy, well-defined bald spots are more consistent with alopecia areata, which is an autoimmune condition.
- Hair loss that started before the medication was prescribed cannot have been caused by it, even if the timeline feels like it overlaps.
If the shedding fits one of those patterns, the right evaluation looks different. The causes of hair loss page is a good starting point for sorting out which category applies.
Other medications that show similar patterns
Gabapentin is one of many medications that have been linked to telogen effluvium in case reports. Others discussed in this section include GLP-1 agonists such as semaglutide, metformin, retinoids such as isotretinoin, certain antidepressants, beta-blockers, and anticoagulants. The general principle is the same across this category: indirect effect on the growth cycle, two to four month delay, often reversible, and a decision about whether to continue belongs with the prescriber.
The medications that cause hair loss overview covers the broader category.
When to consider a hair evaluation
If shedding has continued for more than six months, if it does not fit a typical telogen effluvium pattern, or if you have other features of pattern hair loss in your family history, a structured evaluation can help. Curekey's online assessment lets a licensed clinician review your medications, timing, and pattern alongside the rest of your medical history.
If you would like to start there, you can start a free hair assessment. If you want to read more about the process first, see how it works or the guide to when to talk to a doctor about side effects.
